BD, UNICEF and the US Committee for UNICEF Resolve to Increase Efforts to Eliminate this "Silent Killer" Through Safe Immunization Campaigns.
To view links denoted with this symbol, Adobe Acrobat Reader must be installed on your system.
Originally reluctant, Jan Devi accepts MNT vaccination and describes shot as 'painless'during a campaign conducted in India. (Photo courtesy of Sondeep Shankar/U.S. Committee for UNICEF)
"BD takes very seriously its corporate aim to help eliminate unnecessary suffering and death from disease. MNT is a disease of pain, poverty and neglect that strikes hardest at the most vulnerable. We pledge to expand our efforts in support of this important initiative."
The global plan calls for the safe immunization of over 90 million women worldwide. BD will provide 135 million auto-disable syringes and injection devices50% of what is neededto support this global campaign. BD auto-disable products --
27 countries currently account for 90% of neonatal tetanus cases worldwide. The global plan focuses on combating the disease in high-risk areas of Asia, Africa, the Middle East and the West Pacific, providing three tetanus toxoid immunization rounds for all women of childbearing age.
View excerpts of Dr. Gasse's presentation on MNT and the high-risk approach.
In Dhanela, India, local healthcare workers carry auto-disable syringes used in recent campaign. (Photo courtesy of Sondeep Shankar/U.S. Committee for UNICEF)
Many organizations strengthen the work of the Partnership. Some include:
"The collaboration between BD and UNICEF to bring this scourge to an end...sets the stage to eliminate this killer of children and mothers once and for all. I remind you that we have eliminated smallpox from the face of the earth, we're on the verge of eliminating polio, and, with your help, neonatal tetanus can be next."